🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to assess the safety and tolerability of single dose...
Status
Terminated
Location
Deawoong pharmaceutical
Start Date
2020-12-04
Trial ID
NCT04541485
This is a multiple-dose study in non-treatment seeking male and female subj...
Status
Completed
Location
Vince & Associates Clinical Research
Start Date
2013-11
Trial ID
NCT02044094
Treatments Being Tested
Specific Aim: To conduct a randomized, placebo-controlled trial of extended...
Status
Completed
Location
Yale University
Start Date
2011-03
Trial ID
NCT01246401
Treatments Being Tested
This will be a randomized, double-blind, placebo-controlled trial to assess...
Status
Completed
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT01567527
Treatments Being Tested
The purpose of the trial was to evaluate the efficacy, safety, and tolerabi...
Status
Completed
Location
Otsuka Investigational Site
Start Date
2008-07
Trial ID
NCT00705783
Treatments Being Tested
The purpose of the this trial is to evaluate the efficacy, safety, and tole...
Status
Completed
Location
Multiple Locations
Start Date
2008-09-01
Trial ID
NCT00706654
The primary purpose of this study is to evaluate the overall efficacy of ar...
Status
Completed
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT01663532
Treatments Being Tested
A multinational, multicenter, randomized, Phase III, double blind, parallel...
Status
Completed
Location
Mapi Pharma Research site 08
Start Date
2019-09-19
Trial ID
NCT04121221
This is a phase 3, multicenter, randomized, active-controlled trial to asse...
Status
Completed
Location
Beijing Anding Hospital of Capital Medical University
Start Date
2017-05-15
Trial ID
NCT03172871
Treatments Being Tested
This study is to evaluate the safety and tolerability of single dose of GB-...
Status
Completed
Location
Syneos Health
Start Date
2022-08-26
Trial ID
NCT05525780
Treatments Being Tested